Matches in SemOpenAlex for { <https://semopenalex.org/work/W2984633170> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W2984633170 endingPage "270" @default.
- W2984633170 startingPage "261" @default.
- W2984633170 abstract "Objective: Disease modifying therapies (DMTs) for multiple sclerosis (MS) aim to delay progression and reduce relapses. Evidence is limited on the comparative effectiveness of the oral DMTs fingolimod and teriflunomide. This study evaluated time to treatment failure among patients with MS who initiated fingolimod versus teriflunomide in real-world settings.Methods: The retrospective cohort included 18–64 year old patients diagnosed with MS who initiated fingolimod or teriflunomide during 12 September 2012 to 30 September 2015 within MarketScan Commercial and Medicare Claims. Patients were followed from treatment initiation (index date) until first treatment failure or censoring. Treatment failure was defined as the first occurrence of MS relapse (identified using a validated algorithm) or treatment discontinuation (≥60 day supply gap). Treatment failure was examined through Kaplan–Meier analysis and multivariable Cox regression adjusting for 1 year baseline factors (age, gender, plan type, region, index year, prior DMT use, baseline relapses, Charlson Comorbidity Index [CCI] and MS symptoms).Results: On average, patients treated with fingolimod (n = 2704) were younger (43.6 versus 49.8 years) with lower CCI (0.4 versus 0.7) and more relapses at baseline (0.46 versus 0.42) than those treated with teriflunomide (n = 1859). Median time to treatment failure was 19.5 months with fingolimod versus 9.6 months with teriflunomide (p < .001). After controlling key demographic and clinical characteristics through multivariable regression, fingolimod was associated with 38.9% lower hazards of treatment failure versus teriflunomide (adjusted hazard ratio = 0.611; 95% CI: 0.559–0.669; p < .001).Conclusions: In a large cohort of US adults with MS, controlling for key baseline characteristics, fingolimod was associated with significantly longer time to treatment failure and lower risk of treatment failure compared with teriflunomide." @default.
- W2984633170 created "2019-11-22" @default.
- W2984633170 creator A5014261732 @default.
- W2984633170 creator A5016178865 @default.
- W2984633170 creator A5062902413 @default.
- W2984633170 creator A5065966188 @default.
- W2984633170 creator A5076130466 @default.
- W2984633170 creator A5090350403 @default.
- W2984633170 creator A5090965713 @default.
- W2984633170 date "2019-12-05" @default.
- W2984633170 modified "2023-09-23" @default.
- W2984633170 title "Time to treatment failure following initiation of fingolimod versus teriflunomide for multiple sclerosis: a retrospective US claims study" @default.
- W2984633170 cites W1984705645 @default.
- W2984633170 cites W1999493557 @default.
- W2984633170 cites W2014094373 @default.
- W2984633170 cites W2043591841 @default.
- W2984633170 cites W2061326496 @default.
- W2984633170 cites W2063844762 @default.
- W2984633170 cites W2067338532 @default.
- W2984633170 cites W2071806619 @default.
- W2984633170 cites W2096479500 @default.
- W2984633170 cites W2104948944 @default.
- W2984633170 cites W2118735809 @default.
- W2984633170 cites W2127837073 @default.
- W2984633170 cites W2129967156 @default.
- W2984633170 cites W2132555717 @default.
- W2984633170 cites W2133329597 @default.
- W2984633170 cites W2138992948 @default.
- W2984633170 cites W2151340435 @default.
- W2984633170 cites W2159712156 @default.
- W2984633170 cites W2172138286 @default.
- W2984633170 cites W2173315418 @default.
- W2984633170 cites W2342072354 @default.
- W2984633170 cites W2404742406 @default.
- W2984633170 cites W2587994165 @default.
- W2984633170 cites W2738424705 @default.
- W2984633170 cites W2748194760 @default.
- W2984633170 cites W2910356129 @default.
- W2984633170 doi "https://doi.org/10.1080/03007995.2019.1690440" @default.
- W2984633170 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31694401" @default.
- W2984633170 hasPublicationYear "2019" @default.
- W2984633170 type Work @default.
- W2984633170 sameAs 2984633170 @default.
- W2984633170 citedByCount "4" @default.
- W2984633170 countsByYear W29846331702020 @default.
- W2984633170 countsByYear W29846331702021 @default.
- W2984633170 crossrefType "journal-article" @default.
- W2984633170 hasAuthorship W2984633170A5014261732 @default.
- W2984633170 hasAuthorship W2984633170A5016178865 @default.
- W2984633170 hasAuthorship W2984633170A5062902413 @default.
- W2984633170 hasAuthorship W2984633170A5065966188 @default.
- W2984633170 hasAuthorship W2984633170A5076130466 @default.
- W2984633170 hasAuthorship W2984633170A5090350403 @default.
- W2984633170 hasAuthorship W2984633170A5090965713 @default.
- W2984633170 hasConcept C126322002 @default.
- W2984633170 hasConcept C167135981 @default.
- W2984633170 hasConcept C203014093 @default.
- W2984633170 hasConcept C207103383 @default.
- W2984633170 hasConcept C2776036978 @default.
- W2984633170 hasConcept C2777703276 @default.
- W2984633170 hasConcept C2778715236 @default.
- W2984633170 hasConcept C2780640218 @default.
- W2984633170 hasConcept C44249647 @default.
- W2984633170 hasConcept C50382708 @default.
- W2984633170 hasConcept C71924100 @default.
- W2984633170 hasConceptScore W2984633170C126322002 @default.
- W2984633170 hasConceptScore W2984633170C167135981 @default.
- W2984633170 hasConceptScore W2984633170C203014093 @default.
- W2984633170 hasConceptScore W2984633170C207103383 @default.
- W2984633170 hasConceptScore W2984633170C2776036978 @default.
- W2984633170 hasConceptScore W2984633170C2777703276 @default.
- W2984633170 hasConceptScore W2984633170C2778715236 @default.
- W2984633170 hasConceptScore W2984633170C2780640218 @default.
- W2984633170 hasConceptScore W2984633170C44249647 @default.
- W2984633170 hasConceptScore W2984633170C50382708 @default.
- W2984633170 hasConceptScore W2984633170C71924100 @default.
- W2984633170 hasIssue "2" @default.
- W2984633170 hasLocation W29846331701 @default.
- W2984633170 hasLocation W29846331702 @default.
- W2984633170 hasOpenAccess W2984633170 @default.
- W2984633170 hasPrimaryLocation W29846331701 @default.
- W2984633170 hasRelatedWork W1532617462 @default.
- W2984633170 hasRelatedWork W1985944010 @default.
- W2984633170 hasRelatedWork W2316458168 @default.
- W2984633170 hasRelatedWork W2739756297 @default.
- W2984633170 hasRelatedWork W2904316116 @default.
- W2984633170 hasRelatedWork W2971309441 @default.
- W2984633170 hasRelatedWork W3030177861 @default.
- W2984633170 hasRelatedWork W4235416836 @default.
- W2984633170 hasRelatedWork W4283512998 @default.
- W2984633170 hasRelatedWork W2291724758 @default.
- W2984633170 hasVolume "36" @default.
- W2984633170 isParatext "false" @default.
- W2984633170 isRetracted "false" @default.
- W2984633170 magId "2984633170" @default.
- W2984633170 workType "article" @default.